« Back to Record
Eggermont, A. A., Suciu, S., Santinami, M., Testori, A., Kruit, W. H., Marsden, J., Punt, C., Sales, F., Gore, M., Mackie, R., Kusic, Z., Dummer, R., Hauschild, A., Musat, E., Spatz, A., & Keilholz, U. (2008). Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet, 372(9633), 117-126. doi:10.1016/S0140-6736(08)61033-8
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/176187



